Close Menu
Daily Guardian
  • Home
  • News
  • Politics
  • Business
  • Entertainment
  • Lifestyle
  • Health
  • Sports
  • Technology
  • Climate
  • Auto
  • Travel
  • Web Stories
What's On

MEXC Lists 20 New Ondo Tokenized Stocks with Zero-Fee Trading

March 30, 2026

Pancreatic Adenocarcinoma Treatment Market to Grow at 13% CAGR During 2026-2030, Led by Pfizer, Roche, Merck & Co., Sanofi, Bristol-Myers Squibb, AstraZeneca, Novartis, and GlaxoSmithKline

March 30, 2026

Paraganglioma Market Trends and Investment Opportunities 2026-2030

March 30, 2026

Brian Ferdinand Joins Forbes Finance Council, Marking Key Milestone for EverForward Trading

March 30, 2026

Neuroblastoma Market Analysis Report 2026-2030 | Rising Childhood Cancer Incidence Fuels Demand | Identify Lucrative Growth Segments for Investment Purposes

March 30, 2026
Facebook X (Twitter) Instagram
Finance Pro
Facebook X (Twitter) Instagram
Daily Guardian
Subscribe
  • Home
  • News
  • Politics
  • Business
  • Entertainment
  • Lifestyle
  • Health
  • Sports
  • Technology
  • Climate
  • Auto
  • Travel
  • Web Stories
Daily Guardian
Home ยป Pet Microchips Market Analysis Report 2026 with Detailed Segmental and Regional Forecasts to 2033
Press Release

Pet Microchips Market Analysis Report 2026 with Detailed Segmental and Regional Forecasts to 2033

By News RoomMarch 30, 20264 Mins Read
Pet Microchips Market Analysis Report 2026 with Detailed Segmental and Regional Forecasts to 2033
Share
Facebook Twitter LinkedIn Pinterest Email

Dublin, March 30, 2026 (GLOBE NEWSWIRE) — The “Pet Microchips Market Size, Share & Trends Analysis Report by Pet, Product, Frequency, Application, Distribution Channel, Region, and Segment Forecasts, 2026-2033” has been added to ResearchAndMarkets.com’s offering.

The global pet microchips market, valued at USD 444.1 million in 2025, is anticipated to grow to USD 972.1 million by 2033, attaining a compound annual growth rate (CAGR) of 10.6% from 2026 to 2033. This surge is primarily driven by the increasing concern for pet safety, rising pet expenditures, and the growing trend of pet humanization, along with regulatory standardization in pet identification.

Pet safety practices are evolving globally, emphasizing structured pet population management and traceability to enhance animal welfare and public health. Brazil’s SinPatinhas initiative, part of the ProPatinhas program launched in April 2025, underscores this trend. By implementing a lifetime, non-transferable Animal ID with centralized registry microchip information, the program aids in preventing pet loss, reducing abandonment, and ensuring traceability throughout an animal’s life.

Coupled with vaccination, castration, and zoonosis-control campaigns, this initiative encourages the normalization of microchips in responsible pet ownership, boosting sustained adoption and market expansion in Brazil. Seasonal increases in pet loss, especially during high-risk summer months, further spotlight the importance of permanent identification to reunify lost pets, as highlighted by PetPlace’s Paws for Safety Awareness campaign launched in June 2025.

The escalating pet expenditure in countries like India is another market catalyst, signifying a cultural shift from viewing pets as household animals to emotionally valued family members. This humanization trend leads to increased spending on preventive healthcare, safety solutions, and long-term well-being. As pet owners prioritize health management, traceability, and loss recovery, pet microchipping becomes a cornerstone of responsible pet ownership.

Regulatory interventions increasingly push microchipping adoption, particularly in urban areas where pet management and public safety are pressing concerns. Mandatory identification and licensing frameworks set by municipal authorities are transitioning microchipping from a voluntary measure to a regulatory requisite, broadening the market for pet microchips and associated services.

Pet Microchips Market Segmentation

This report predicts revenue growth at various levels and analyzes industry trends across sub-segments from 2021 to 2033. The pet microchips market report is segmented by pet, product, frequency, application, distribution channel, and region.

Pet Outlook (Revenue, USD Million, 2021-2033)

Product Outlook (Revenue, USD Million, 2021-2033)

Frequency Outlook (Revenue, USD Million, 2021-2033)

  • 134.2 KHz
  • 125 KHz
  • 128 KHz
  • Universal/Multifrequency Devices

Application Outlook (Revenue, USD Million, 2021-2033)

  • Pet Identification
  • Disease Tracking & Vaccination Management
  • Theft Prevention
  • Others

Distribution Channel Outlook (Revenue, USD Million, 2021-2033)

  • Veterinary Hospitals/Clinics
  • Pet Stores/Retail
  • E-Commerce
  • Others

Region Outlook (Revenue, USD Million, 2021-2033)

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Why You Should Buy This Report

  • Comprehensive Market Analysis: Gain detailed insights into the market across major regions and segments.
  • Competitive Landscape: Explore the market presence of key players.
  • Future Trends: Discover pivotal trends and drivers shaping the market’s future.
  • Actionable Recommendations: Utilize insights for new revenue streams and strategic business decisions.

This report addresses:

  • Market intelligence for effective decision-making
  • Market estimates and forecasts from 2018 to 2030
  • Growth opportunities and trend analyses
  • Segment and regional revenue forecasts for market assessment
  • Competition strategy and market share analysis
  • Product innovation listings to stay ahead of the curve

Key Attributes

Report Attribute Details
No. of Pages 150
Forecast Period 2025-2033
Estimated Market Value (USD) in 2025 $444.1 Million
Forecasted Market Value (USD) by 2033 $972.1 Million
Compound Annual Growth Rate 10.6%
Regions Covered Global

The leading players profiled in this Pet Microchips market report include:

  • Merck & Co., Inc.
  • Peeva Inc.
  • Virbac
  • Trovan Ltd.
  • Wuxi Fofia Technology Co., Ltd.
  • Avid Identification Systems, Inc.
  • Datamars Animal ID (Datamars)
  • Microchip Identification Systems
  • Pet Pulse
  • Elanco

For more information about this report visit https://www.researchandmarkets.com/r/vjxh9k

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.


            
Share. Facebook Twitter Pinterest LinkedIn Tumblr Email

Keep Reading

MEXC Lists 20 New Ondo Tokenized Stocks with Zero-Fee Trading

Pancreatic Adenocarcinoma Treatment Market to Grow at 13% CAGR During 2026-2030, Led by Pfizer, Roche, Merck & Co., Sanofi, Bristol-Myers Squibb, AstraZeneca, Novartis, and GlaxoSmithKline

Paraganglioma Market Trends and Investment Opportunities 2026-2030

Brian Ferdinand Joins Forbes Finance Council, Marking Key Milestone for EverForward Trading

Neuroblastoma Market Analysis Report 2026-2030 | Rising Childhood Cancer Incidence Fuels Demand | Identify Lucrative Growth Segments for Investment Purposes

Non-Muscle Invasive Bladder Cancer (NMIBC) Market to Grow by $1 Billion During 2026-2030 – Johnson & Johnson, Janssen Research & Development, and Merck & Co. Lead the Competition

$28+ Billion Cancer Supportive Care Products Market Outlook Report, 2030

Trends and Opportunities in the Chemotherapy-At-Home Services Market, 2026-2030: Total Revenue to Grow by $1 Billion, Led by CVS Health, Optum, and Fresenius Kabi

AI in Oncology for Analytical Solutions Market to Triple in Size During 2026-2030 Registering 34.2% CAGR – IBM Watson Health, NVIDIA Corp., and Siemens Healthineers Dominate the $1.93 Billion Industry

Editors Picks

Pancreatic Adenocarcinoma Treatment Market to Grow at 13% CAGR During 2026-2030, Led by Pfizer, Roche, Merck & Co., Sanofi, Bristol-Myers Squibb, AstraZeneca, Novartis, and GlaxoSmithKline

March 30, 2026

Paraganglioma Market Trends and Investment Opportunities 2026-2030

March 30, 2026

Brian Ferdinand Joins Forbes Finance Council, Marking Key Milestone for EverForward Trading

March 30, 2026

Neuroblastoma Market Analysis Report 2026-2030 | Rising Childhood Cancer Incidence Fuels Demand | Identify Lucrative Growth Segments for Investment Purposes

March 30, 2026

Latest News

Non-Muscle Invasive Bladder Cancer (NMIBC) Market to Grow by $1 Billion During 2026-2030 – Johnson & Johnson, Janssen Research & Development, and Merck & Co. Lead the Competition

March 30, 2026

$28+ Billion Cancer Supportive Care Products Market Outlook Report, 2030

March 30, 2026

Trends and Opportunities in the Chemotherapy-At-Home Services Market, 2026-2030: Total Revenue to Grow by $1 Billion, Led by CVS Health, Optum, and Fresenius Kabi

March 30, 2026
Facebook X (Twitter) Pinterest TikTok Instagram
© 2026 Daily Guardian Canada. All Rights Reserved.
  • Privacy Policy
  • Terms
  • Advertise
  • Contact

Type above and press Enter to search. Press Esc to cancel.

Go to mobile version